Assessing the incidence and severity of drug adverse events: a Bayesian hierarchical cumulative logit model

References

• Agresti, A. 2010. Analysis of ordinal categorical data. 2 ed. Hoboken, New Jersey, USA: John Wiley & Sons, Inc.
   Google Scholar
• Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: A practical and powerful approach to multipletesting. Journal of the Royal Statistical Society: Series B (Methodological) 57 (1):289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
   Web of Science ®Google Scholar
• Berry, S. M., and D. A. Berry. 2004. Accounting for multiplicities in assessing drug safety: A three-level hierarchical mixture model. Biometrics 60 (2):418–426. doi:10.1111/j.0006-341X.2004.00186.x.
   PubMed Web of Science ®Google Scholar
• Cohen, A., and H. B. Sackrowitz. 2000. Testing whether treatment is “better“ than control with ordered categorical data: Definitions and complete class theorems. Statistics and Decisions 18 (1):1–25. doi:10.1524/strm.2000.18.1.1.
   Google Scholar
• Cohen, A., H. B. Sackrowitz, and M. Sackrowitz. 2000. Testing whether treatment is ‘better’ than control with ordered categorical data: An evaluation of new methodology. Statistics in Medicine 19 (19):2699–2712. doi:10.1002/1097-0258(20001015)19:19<2699:AID-SIM560>3.0.CO;2-D.
   PubMed Web of Science ®Google Scholar
• DuMouchel, W. 2012. Multivariate bayesian logistic regression for analysis of clinical study safety issues. Statistical Science 27 (3):319–339. doi:10.1214/11-STS381.
   Web of Science ®Google Scholar
• Gould, A. L. 2008. Detecting potential safety issues in clinical trials by bayesian screening. Biometrical Journal 50 (5):837–851. doi:10.1002/bimj.200710469.
   PubMed Web of Science ®Google Scholar
• Gould, A. L. 2013. Detecting potential safety issues in large clinical or observational trials by bayesian screening when event counts arise from poisson distributions. Journal of Biopharmaceutical Statistics 23 (4):829–847. doi:10.1080/10543406.2013.789887.
   PubMed Web of Science ®Google Scholar
• Gould, A. L. 2018. Unified screening for potential elevated adverse event risk and other associations. Statistics in Medicine 37 (18):2667–2689. doi:10.1002/sim.7686.
   PubMed Web of Science ®Google Scholar
• Jung, M. Y., R. Ward, Z. Xu, J. Xu, Z. Yao, L. Huang, and R. Tiwari. 2021. Application of a likelihood ratio test based method for safety signal detection to left ventricular assist devices. Journal of Biopharmaceutical Statistics 31 (1):47–54. doi:10.1080/10543406.2020.1783282.
   PubMed Web of Science ®Google Scholar
• Klingenberg, B., A. Solari, L. Salmaso, and F. Pesarin. 2009. Testing marginal homogeneity against stochastic order in multivariate ordinal data. Biometrics 65 (2):452–462. doi:10.1111/j.1541-0420.2008.01067.x.
   PubMed Web of Science ®Google Scholar
• Leon-Novelo, L. G., X. Zhou, N. B. Bekele, and P. Muller. 2010. Assessing toxicities in a clinical trial: Bayesian inferencefor ordinal data nested within categories. Biometrics 66 (3):966–974. doi:10.1111/j.1541-0420.2009.01359.x.
   PubMed Web of Science ®Google Scholar
• McKinley, T. J., M. Morters, and J. L. N. Wood. 2015. Bayesian model choice in cumulative link ordinal regression models. Bayesian Analysis 10 (1):1–30. doi:10.1214/14-BA884.
   Web of Science ®Google Scholar
• Mehrotra, D. V., and A. J. Adewale. 2012. Flagging clinical adverse experiences: Reducing false discoveries without materially compromising power for detecting true signals. Statistics in Medicine 31 (18):1918–1930. doi:10.1002/sim.5310.
   PubMed Web of Science ®Google Scholar
• Mehrotra, D. V., and J. F. Heyse. 2004. Use of the false discovery rate for evaluating clinical safety data. Statistical Methods in Medical Research 13 (3):227–238. doi:10.1191/0962280204sm363ra.
   PubMed Web of Science ®Google Scholar
• Neuenschwander, B., S. Wandel, S. Roychoudhury, and S. Bailey. 2015. Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical Statistics 15 (2):123–134. doi:10.1002/pst.1730.
   PubMed Web of Science ®Google Scholar
• Wang, S. V., J. C. Maro, E. Baro, R. Izem, I. Dashevsky, J. R. Rogers, M. Nguyen, J. J. Gagne, E. Patorno, K. F. Huybrechts, et al. 2018. Data mining for adverse drug events with a propensity score matched tree-based scan statistic. Epidemiology 29 (6):895–903. doi:10.1097/EDE.0000000000000907.
   PubMed Web of Science ®Google Scholar
• Xia, H. A., H. Ma, and B. P. Carlin. 2011. Bayesian hierarchical modeling for detecting safety signals in clinical trials. Journal of Biopharmaceutical Statistics 21 (5):1006–1029. doi:10.1080/10543406.2010.520181.
   PubMed Web of Science ®Google Scholar